<%server.execute "isdev.asp"%> A rare cause of acute flaccid paralysis: Human coronaviruses Turgay C, Emine T, Ozlem K, Muhammet S P, Haydar A T - J Pediatr Neurosci
home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 1005      Small font sizeDefault font sizeIncrease font size Print this page Email this page


 
  Table of Contents    
CASE REPORT
Year : 2015  |  Volume : 10  |  Issue : 3  |  Page : 280-281
 

A rare cause of acute flaccid paralysis: Human coronaviruses


1 Department of Pediatrics, Division of Pediatric Neurology, Faculty of Medicine, Ondokuz Mayis University, Kurupelit, 55139 Samsun, Turkey
2 Department of Pediatrics, Pediatric Intensive Care Unit, Faculty of Medicine, Ondokuz Mayis University, Kurupelit, 55139 Samsun, Turkey

Date of Web Publication18-Sep-2015

Correspondence Address:
Cokyaman Turgay
Department of Pediatrics, Division of Pediatric Neurology, Faculty of Medicine, Ondokuz Mayis University, Kurupelit, 55139 Samsun
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1817-1745.165716

Rights and Permissions

 

   Abstract 

Acute flaccid paralysis (AFP) is a life-threatening clinical entity characterized by weakness in the whole body muscles often accompanied by respiratory and bulbar paralysis. The most common cause is Gullian-Barre syndrome, but infections, spinal cord diseases, neuromuscular diseases such as myasthenia gravis, drugs and toxins, periodic hypokalemic paralysis, electrolyte disturbances, and botulism should be considered as in the differential diagnosis. Human coronaviruses (HCoVs) cause common cold, upper and lower respiratory tract disease, but in the literature presentation with the lower respiratory tract infection and AFP has not been reported previously. In this study, pediatric case admitted with lower respiratory tract infection and AFP, who detected for HCoV 229E and OC43 co-infection by the real-time polymerase chain reaction, has been reported for the first time.


Keywords: Acute flaccid paralysis, child, coronavirus 229E, coronavirus OC43


How to cite this article:
Turgay C, Emine T, Ozlem K, Muhammet S P, Haydar A T. A rare cause of acute flaccid paralysis: Human coronaviruses. J Pediatr Neurosci 2015;10:280-1

How to cite this URL:
Turgay C, Emine T, Ozlem K, Muhammet S P, Haydar A T. A rare cause of acute flaccid paralysis: Human coronaviruses. J Pediatr Neurosci [serial online] 2015 [cited 2021 Nov 30];10:280-1. Available from: https://www.pediatricneurosciences.com/text.asp?2015/10/3/280/165716



   Introduction Top


Acute flaccid paralysis (AFP) is a clinical entity characterized by areflexia and/or hyporeflexia and weakness which reaches a maximum within days or weeks. [1] Polioviruses, enterovirus 71, flavivirus, herpes virus, and rabies virus are well-known as viral etiologic agents. [2] In this article, who presented with lower respiratory tract infection and AFP, and was detected to have co-infection of human coronavirus (HCoV) 229E and OC43 is reported. AFP associated with HCoV infections has not been reported previously in the literature, and has been reported for the first time in this article.


   Case Report Top


A 3-year-old girl hospitalized due to the development of shortness of breath and inability to walk 1-day after the beginning of fever, rhinorrhea, cough, and weakness. On the same day, respiratory distress increased, she was intubated, and mechanical ventilation started. On physical examination, she was conscious but swallowing, chewing and speech functions damaged, muscle strength was 0/5 and deep tendon reflexes (DTRs) were absent, the plantar response was flexor. Physical examination of other systems was normal. Complete blood count, electrolytes and blood biochemistry and urinalysis were normal, C-reactive protein was negative and erythrocyte sedimentation rate was 20 mm/h. Chest radiography was normal. Cerebrospinal fluid (CSF) pressure, glucose, and protein were normal. Blood, urine, and CSF cultures were negative. Stool and nasal swab cultures were taken. Electroneuromyography (ENMG) revealed no pathological findings. No abnormalities in the brain and spinal cord magnetic resonance imaging were detected - so intracranial and spinal pathologies were excluded.

Intravenous antibiotherapy was given for 10 days. After 48 h of hospitalization, a total of 2 g/kg intravenous immunoglobulin (IVIG) in 3 days was given. Mechanical ventilation lasted 7 days. At the end of this period, muscle strength improved to 2-3/5, DTR became norm active, bulbar paralysis and respiratory distress had regressed. At the end of the 2 nd week, she could mobilize and walk with a guide. Lumbar puncture and ENMG repeated in the 3 rd week did not reveal any pathological findings and Gullian-Barre syndrome (GBS) was completely excluded. Real-time polymerase chain reaction (PCR) analysis of nasal swab samples was reported to be positive for HCoV 229E and OC43 and HCoV co-infection was diagnosed.


   Discussion Top


Flaccid paralysis occurs by the damage of lower motor neurons in the anterior horn of the spinal cord or peripheral nerves either by direct invasion or parainfectious and/or postinfectious immune-mediated mechanisms. [2] Besides GBS, differential diagnosis of AFP includes: Compressive and inflammatory diseases of spinal cord, the anterior horn motor neurons involvement by infectious (poliomyelitis vaccine-associated poliomyelitis, other enteroviral myelitis, a Japanese encephalitis, and West Nile virus as agents) and vascular pathology, myasthenia gravis, drug and toxins affecting neuromuscular junction (aminoglycosides, organophosphates, snake venom and botulism, etc.), muscle disease such as viral myositis or inflammatory myopathy, hypokalemic periodic paralysis and electrolyte disorders (hypermagnesemia and hypokalemia). [3]

Preliminary diagnosis was GBS for this case; however, CSF and ENMG findings in the 1 st week of paralysis did not support this diagnosis. During the period of mechanical ventilation muscle strength increased and in this short time DTR normalized, as well as after 3 weeks paralysis started no pathologic findings observed by repeating lumbar puncture and ENMG so GBS was excluded. History, clinical presentation, physical examination, and laboratory tests were totally normal that ruled out toxicological etiology, polio, and botulismus.

Members of coronaviridae can cause respiratory, intestinal, hepatic and neurological diseases of various severities in humans and animals. [4] In particular, HCoV OC43 is a neurotrophic, neuroinvasive and neuroinflammatory virus. Experimental animal studies reported that HCoV OC43 causes flaccid paralysis and demyelination. [5] HCoVs can cause neurological symptoms such as seizures and meningoencephalitis in children [6] but AFP has not been reported until now.

HCoVs may cause more serious respiratory disease in case of immune suppression and with various respiratory agents rather than single infection. [7] In addition HCoV, 229 and OC43 co-infection causing more severe respiratory disease has been demonstrated by a study. [8] We have reported case of co-infection with HCoV 229E and OC43 detected by real-time PCR analysis of nasal swab samples, and additional different respiratory pathogen has not been demonstrated, it suggests that co-infection caused lower respiratory tract infection and AFP.

We believe that HCoV 229E and OC43 co-infection may cause respiratory failure and AFP. Whether IVIG have a role in the treatment needs to be supported by more data from the literature.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev 2000;22:298-316.  Back to cited text no. 1
    
2.
Solomon T, Willison H. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 2003;16:375-81.  Back to cited text no. 2
    
3.
Singhi SC, Sankhyan N, Shah R, Singhi P. Approach to a child with acute flaccid paralysis. Indian J Pediatr 2012;79:1351-7.  Back to cited text no. 3
    
4.
Jevšnik M, Uršic T, Zigon N, Lusa L, Krivec U, Petrovec M. Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease. BMC Infect Dis 2012;12:365.  Back to cited text no. 4
    
5.
Brison E, Jacomy H, Desforges M, Talbot PJ. Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein. J Virol 2011;85:12464-73.  Back to cited text no. 5
    
6.
Dominguez SR, Robinson CC, Holmes KV. Detection of four human coronaviruses in respiratory infections in children: A one-year study in Colorado. J Med Virol 2009;81:1597-604.  Back to cited text no. 6
    
7.
Gerna G, Campanini G, Rovida F, Percivalle E, Sarasini A, Marchi A, et al. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 2006;78:938-49.  Back to cited text no. 7
    
8.
Walsh EE, Shin JH, Falsey AR. Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. J Infect Dis 2013;208:1634-42.  Back to cited text no. 8
    



This article has been cited by
1 Neuroinvasive potential of human coronavirus OC43: case report of fatal encephalitis in an immunocompromised host
Masumbuko C. Kasereka, Michael T. Hawkes
Journal of NeuroVirology. 2021; 27(2): 340
[Pubmed] | [DOI]
2 Neuropathies and neurological dysfunction induced by coronaviruses
Mina Gholami, Sepideh Safari, Luis Ulloa, Majid Motaghinejad
Journal of NeuroVirology. 2021; 27(3): 380
[Pubmed] | [DOI]
3 Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study
Felipe Henriques Carvalho Soares, Gabriel Taricani Kubota, Ana Mércia Fernandes, Bruno Hojo, Catarina Couras, Bárbara Venturoti Costa, Jorge Dornellys da Silva Lapa, Luíza Mansur Braga, Matheus Merula de Almeida, Pedro Henrique Martins da Cunha, Vítor Hugo Honorato Pereira, Adriano Donizeth Silva de Morais, Manoel Jacobsen Teixeira, Daniel Ciampi de Andrade
European Journal of Pain. 2021; 25(6): 1342
[Pubmed] | [DOI]
4 Coronavirus Infections in the Nervous System of Children: A Scoping Review Making the Case for Long-Term Neurodevelopmental Surveillance
Timothy G. Singer, Karen D. Evankovich, Kristen Fisher, Gail J. Demmler-Harrison, Sarah R. Risen
Pediatric Neurology. 2021; 117: 47
[Pubmed] | [DOI]
5 Human and novel coronavirus infections in children: a review
Nipunie Rajapakse, Devika Dixit
Paediatrics and International Child Health. 2021; 41(1): 36
[Pubmed] | [DOI]
6 Systematic review of cases of acute myelitis in individuals with COVID-19
Eva C. Schulte, Larissa Hauer, Alexander B. Kunz, Johann Sellner
European Journal of Neurology. 2021; 28(10): 3230
[Pubmed] | [DOI]
7 Potential Differences in Cleavage of the S Protein and Type 1 Interferon Together Control Human Coronavirus Infection, Propagation, and Neuropathology within the Central Nervous System
Alain Le Coupanec, Marc Desforges, Benedikt Kaufer, Philippe Dubeau, Marceline Côté, Pierre J. Talbot, Tom Gallagher
Journal of Virology. 2021; 95(10)
[Pubmed] | [DOI]
8 Can other coronavirus infections cause a cryptogenic stroke in a young patient?
Ze'ev Itsekson Hayosh, Yvonne Schwammenthal, David Orion
BMJ Case Reports. 2021; 14(3): e239113
[Pubmed] | [DOI]
9 SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents
Anna Fagre, Juliette Lewis, Miles Eckley, Shijun Zhan, Savannah M. Rocha, Nicole R. Sexton, Bradly Burke, Brian Geiss, Olve Peersen, Todd Bass, Rebekah Kading, Joel Rovnak, Gregory D. Ebel, Ronald B. Tjalkens, Tawfik Aboellail, Tony Schountz, David Wang
PLOS Pathogens. 2021; 17(5): e1009585
[Pubmed] | [DOI]
10 Overview of COVID-19 and neurological complications
Nasrin Hosseini, Shabnam Nadjafi, Behnaz Ashtary
Reviews in the Neurosciences. 2021; 32(6): 671
[Pubmed] | [DOI]
11 SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
Shahrzad Shoraka, Maria Lucia Brito Ferreira, Seyed Reza Mohebbi, Amir Ghaemi
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
12 Neurology and the COVID-19 Pandemic
Brigit High, Alison M. Hixon, Kenneth L. Tyler, Amanda L. Piquet, Victoria S. Pelak
Neurology: Clinical Practice. 2021; 11(2): e48
[Pubmed] | [DOI]
13 Guillain-Barre Syndrome in a Child Infected with COVID-19
Sedigheh Rafiei Tabatabaei, Ghazal Shariatpanahi, Romina Azadkiya, Parvaneh Karimzadeh, Abdollah Karimi
Archives of Pediatric Infectious Diseases. 2021; In Press(In Press)
[Pubmed] | [DOI]
14 COVID-19 and neuromuscular disorders
Amanda C. Guidon, Anthony A. Amato
Neurology. 2020; 94(22): 959
[Pubmed] | [DOI]
15 Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
Abrahão Fontes Baptista, Adriana Baltar, Alexandre Hideki Okano, Alexandre Moreira, Ana Carolina Pinheiro Campos, Ana Mércia Fernandes, André Russowsky Brunoni, Bashar W. Badran, Clarice Tanaka, Daniel Ciampi de Andrade, Daniel Gomes da Silva Machado, Edgard Morya, Eduardo Trujillo, Jaiti K. Swami, Joan A. Camprodon, Katia Monte-Silva, Katia Nunes Sá, Isadora Nunes, Juliana Barbosa Goulardins, Marom Bikson, Pedro Sudbrack-Oliveira, Priscila de Carvalho, Rafael Jardim Duarte-Moreira, Rosana Lima Pagano, Samuel Katsuyuki Shinjo, Yossi Zana
Frontiers in Neurology. 2020; 11
[Pubmed] | [DOI]
16 Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient
Meret Huber, Sophia Rogozinski, Wolfram Puppe, Carsten Framme, Günter Höglinger, Karsten Hufendiek, Florian Wegner
Frontiers in Neurology. 2020; 11
[Pubmed] | [DOI]
17 Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes
Matteo Briguglio, Alberto Bona, Mauro Porta, Bernardo Dell'Osso, Fabrizio Ernesto Pregliasco, Giuseppe Banfi
Frontiers in Physiology. 2020; 11
[Pubmed] | [DOI]
18 SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms
Manuela Pennisi, Giuseppe Lanza, Luca Falzone, Francesco Fisicaro, Raffaele Ferri, Rita Bella
International Journal of Molecular Sciences. 2020; 21(15): 5475
[Pubmed] | [DOI]
19 COVID-19 associate neurological complications
Leyla Baysal-Kirac, Hilmi Uysal
Neurological Sciences and Neurophysiology. 2020; 37(1): 1
[Pubmed] | [DOI]
20 Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report
Muhammad Durrani, Kevin Kucharski, Zachary Smith, Stephanie Fien
Clinical Practice and Cases in Emergency Medicine. 2020; 4(3): 344
[Pubmed] | [DOI]
21 Coronavirus, Its Neurologic Manifestations, and Complications
Mahmoud Reza Ashrafi, Reza Azizimalamiri, Reza Shervin Badv, Ali Reza Tavasoli, Ali Nikkhah, Hadi Montazerlotfelahi, Mohammad Vafaee-Shahi, Morteza Heidari
Iranian Journal of Pediatrics. 2020; 30(2)
[Pubmed] | [DOI]
22 Clinical and pathogenetic aspects of nervous system impairments in COVID-19
M.A. Kutlubaev
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2020; 120(9): 130
[Pubmed] | [DOI]
23 THE NERVOUS SYSTEM DAMAGE IN COVID-19 PATIENTS
Vladimir V. Belopasov, Ekaterina M. Samoilova, Vladimir P. Baklaushev
Journal of Clinical Practice. 2020;
[Pubmed] | [DOI]
24 Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19
M. Morris, V.M. Zohrabian
American Journal of Neuroradiology. 2020; 41(6): E37
[Pubmed] | [DOI]
25 COVID-19: A Review for the Pediatric Neurologist
Alison Christy
Journal of Child Neurology. 2020; 35(13): 934
[Pubmed] | [DOI]
26 Neurologic Manifestations of Severe Respiratory Viral Contagions
Christopher P. Robinson, Katharina M. Busl
Critical Care Explorations. 2020; 2(4): e0107
[Pubmed] | [DOI]
27 Miastenia gravis asociada a la infección por SARS-CoV-2: una conjunción de factores
Laia Mas Maresma, Oriol Barrachina Esteve, Marta Navarro Vilasaró, Marc Moreno-Ariño
Revista Española de Geriatría y Gerontología. 2020; 55(6): 360
[Pubmed] | [DOI]
28 Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital
Donatella Ottaviani, Federica Boso, Enzo Tranquillini, Ilaria Gapeni, Giovanni Pedrotti, Susanna Cozzio, Giovanni M Guarrera, Bruno Giometto
Neurological Sciences. 2020; 41(6): 1351
[Pubmed] | [DOI]
29 Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
Joy D. Iroegbu, Chibuzor W. Ifenatuoha, Omamuyovwi M. Ijomone
Neurological Sciences. 2020; 41(6): 1329
[Pubmed] | [DOI]
30 Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports
Kaveh Rahimi
Neurological Sciences. 2020; 41(11): 3149
[Pubmed] | [DOI]
31 COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Tahmineh Mokhtari, Fatemeh Hassani, Neda Ghaffari, Babak Ebrahimi, Atousa Yarahmadi, Ghomareza Hassanzadeh
Journal of Molecular Histology. 2020; 51(6): 613
[Pubmed] | [DOI]
32 Neurological Implications of COVID-19 Infections
Edward J. Needham, Sherry H.-Y. Chou, Alasdair J. Coles, David K. Menon
Neurocritical Care. 2020; 32(3): 667
[Pubmed] | [DOI]
33 Coronaviruses and the central nervous system
Susan Morgello
Journal of NeuroVirology. 2020; 26(4): 459
[Pubmed] | [DOI]
34 Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review
V. Montalvan, J. Lee, T. Bueso, J. De Toledo, K. Rivas
Clinical Neurology and Neurosurgery. 2020; 194: 105921
[Pubmed] | [DOI]
35 Infectivity of human coronavirus in the brain
Qi Cheng, Yue Yang, Jianqun Gao
EBioMedicine. 2020; 56: 102799
[Pubmed] | [DOI]
36 Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic
Maryam Sharifian-Dorche, Philippe Huot, Michael Osherov, Dingke Wen, Alexander Saveriano, Paul S Giacomini, Jack P Antel, Ashkan Mowla
Journal of the Neurological Sciences. 2020; 417: 117085
[Pubmed] | [DOI]
37 How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy
Daniele Armocida, Mauro Palmieri, Alessandro Frati, Antonio Santoro, Alessandro Pesce
Journal of Clinical Neuroscience. 2020; 79: 231
[Pubmed] | [DOI]
38 ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
J. Matías-Guiu, U. Gomez-Pinedo, P. Montero-Escribano, P. Gomez-Iglesias, J. Porta-Etessam, J.A. Matias-Guiu
Neurología. 2020; 35(3): 170
[Pubmed] | [DOI]
39 Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
J. Matías-Guiu, U. Gomez-Pinedo, P. Montero-Escribano, P. Gomez-Iglesias, J. Porta-Etessam, J.A. Matias-Guiu
Neurología (English Edition). 2020; 35(3): 170
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
 
 
  Search
 
  
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (305 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Case Report
   Discussion
    References

 Article Access Statistics
    Viewed3424    
    Printed69    
    Emailed0    
    PDF Downloaded129    
    Comments [Add]    
    Cited by others 39    

Recommend this journal